Remdesivir for COVID-19: match-population analysis with compassionate use of Remdesivir for severe COVID-19
preprint
OA: gold
CC-BY-NC-ND-4.0
Abstract
We retrospectively compared outcomes between patients who received compassionate care Remdesivir and whose who met criteria for Remdesivir, but did not received it due to period of unavailability. We observed comparable mortality rate and significantly higher mortality rate among patients with CrCl < 30 ml per minute.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-ND-4.0